Package 49702-227-13

Brand: tivicay

Generic: dolutegravir sodium
NDC Package

Package Facts

Identity

Package NDC 49702-227-13
Digits Only 4970222713
Product NDC 49702-227
Description

30 TABLET, FILM COATED in 1 BOTTLE (49702-227-13)

Marketing

Marketing Status
Discontinued 2027-05-31
Brand tivicay
Generic dolutegravir sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a9175b83-2200-4bd2-9ee3-52095b5d2657", "openfda": {"upc": ["0349702227132", "0349702226135", "0349702228139"], "unii": ["1Q1V9V5WYQ"], "rxcui": ["1433873", "1433879", "1796077", "1796079", "1796081", "1796083", "2374562", "2374566"], "spl_set_id": ["63df5af3-b8ac-4e76-9830-2dbb340af922"], "manufacturer_name": ["ViiV Healthcare Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (49702-227-13)", "package_ndc": "49702-227-13", "marketing_end_date": "20270531", "marketing_start_date": "20160609"}], "brand_name": "Tivicay", "product_id": "49702-227_a9175b83-2200-4bd2-9ee3-52095b5d2657", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["HIV Integrase Inhibitors [MoA]", "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]", "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "49702-227", "generic_name": "dolutegravir sodium", "labeler_name": "ViiV Healthcare Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tivicay", "active_ingredients": [{"name": "DOLUTEGRAVIR SODIUM", "strength": "25 mg/1"}], "application_number": "NDA204790", "marketing_category": "NDA", "marketing_end_date": "20270531", "marketing_start_date": "20160609"}